Toxicity of molecular targeted agents in lung cancer. Do we need a new classification?

被引：0
|
作者：
Jassem, Jacek [1 ]
机构：
[1] Med Univ Gdansk, Dept Radiotherapy & Oncol, Gdansk, Poland
来源：
LUNG CANCER | 2012年 / 77卷
关键词：
D O I：
10.1016/j.lungcan.2012.05.010
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S5 / S6
页数：2
相关论文
共 50 条
  • [31] New Targeted Agents in Endometrial Cancer: Are We Really Making Progress?
    Rodriguez-Freixinos, Victor
    Karakasis, Katherine
    Oza, Amit M.
    [J]. CURRENT ONCOLOGY REPORTS, 2016, 18 (04) : 1 - 12
  • [32] DO WE NEED A "TWO WEEK RULE" REFERRAL PATHWAY FOR LUNG CANCER?
    Ali, M. H.
    Berry, A.
    Van Griethuysen, J.
    Peters, H.
    Jameel, A.
    Haji, G.
    Shora, F.
    Berry, M. P.
    Bowen, E. F.
    [J]. THORAX, 2011, 66 : A161 - A162
  • [33] Targeted therapies for small cell lung cancer: Where do we stand?
    Arcaro, Alexandre
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 95 (02) : 154 - 164
  • [34] Skin cancer burden in lung transplant recipients: we need to do better!
    Proby, C. M.
    Harwood, C. A.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (03) : 416 - 417
  • [35] Air pollution and lung cancer: what more do we need to know?
    Cohen, AJ
    [J]. THORAX, 2003, 58 (12) : 1010 - 1012
  • [36] Targeted screening for lung cancer is here but who do we target and how?
    Baldwin, David
    O'Dowd, Emma
    Ten Haaf, Kevin
    [J]. THORAX, 2020, 75 (08) : 617 - 618
  • [37] Endosonographic and histopathological staging of extrahepatic bile duct cancer: Do we need a new TNM-classification?
    Domagk, D
    Diallo, R
    Poremba, C
    Schleicher, C
    Bankfalvi, A
    Domschke, W
    Menzel, J
    [J]. GASTROINTESTINAL ENDOSCOPY, 2004, 59 (05) : AB228 - AB228
  • [38] Do we need inverse MC treatment planning for ESRS of lung cancer?
    Bogner, L
    Moravek, Z
    Rickhey, M
    [J]. RADIOTHERAPY AND ONCOLOGY, 2005, 76 : S172 - S172
  • [39] Do we need prophylactic anticoagulation in ambulatory patients with lung cancer? A review
    Dimakakos, Evangelos
    Kotteas, Elias
    Gomatou, Georgia
    Katsarou, Theodora
    Vlahakos, Vassilis
    Vathiotis, Ioannis
    Talagani, Sofia
    Dimitroulis, Ioannis
    Syrigos, Konstantinos
    [J]. VASCULAR MEDICINE, 2020, 25 (03) : 255 - 262
  • [40] Molecular targeted agents—where we are and where we are going
    Li Yan
    [J]. 癌症, 2013, 32 (05) : 225 - 232
12345